A detailed history of Rfg Holdings, Inc. transactions in Eli Lilly & CO stock. As of the latest transaction made, Rfg Holdings, Inc. holds 343 shares of LLY stock, worth $278,450. This represents 0.11% of its overall portfolio holdings.

Number of Shares
343
Previous 324 5.86%
Holding current value
$278,450
Previous $293,000 3.41%
% of portfolio
0.11%
Previous 0.11%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 10, 2024

BUY
$772.14 - $960.02 $14,670 - $18,240
19 Added 5.86%
343 $303,000
Q2 2024

Jul 15, 2024

BUY
$724.87 - $909.04 $18,121 - $22,726
25 Added 8.36%
324 $293,000
Q1 2024

Apr 15, 2024

BUY
$592.2 - $792.28 $177,067 - $236,891
299 New
299 $232,000

Others Institutions Holding LLY

About ELI LILLY & Co


  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $771B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track Rfg Holdings, Inc. Portfolio

Follow Rfg Holdings, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Rfg Holdings, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Rfg Holdings, Inc. with notifications on news.